Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ticagrelor in patients with heart failure after acute coronary syndromes-Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial.
Åkerblom A, Wojdyla DM, Wallentin L, James SK, de Souza Brito F, Steg PG, Cannon CP, Katus HA, Himmelmann A, Storey RF, Becker RC, Lopes RD; PLATO Investigators. Åkerblom A, et al. Among authors: de souza brito f. Am Heart J. 2019 Jul;213:57-65. doi: 10.1016/j.ahj.2019.04.006. Epub 2019 Apr 18. Am Heart J. 2019. PMID: 31108273 Clinical Trial.
Noncardiovascular deaths are more common than cardiovascular deaths in patients with cardiovascular disease or cardiovascular risk factors and impaired glucose tolerance: Insights from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial.
Sharma A, de Souza Brito F, Sun JL, Thomas L, Haffner S, Holman RR, Lopes RD. Sharma A, et al. Among authors: de souza brito f. Am Heart J. 2017 Apr;186:73-82. doi: 10.1016/j.ahj.2016.12.011. Epub 2016 Dec 29. Am Heart J. 2017. PMID: 28454835
Neuromuscular electrical stimulation improves exercise tolerance in patients with advanced heart failure on continuous intravenous inotropic support use-randomized controlled trial.
Forestieri P, Bolzan DW, Santos VB, Moreira RSL, de Almeida DR, Trimer R, de Souza Brito F, Borghi-Silva A, de Camargo Carvalho AC, Arena R, Gomes WJ, Guizilini S. Forestieri P, et al. Among authors: de souza brito f. Clin Rehabil. 2018 Jan;32(1):66-74. doi: 10.1177/0269215517715762. Epub 2017 Jun 21. Clin Rehabil. 2018. PMID: 28633534 Clinical Trial.
Percutaneous mechanical assistance for the failing heart.
de Souza CF, de Souza Brito F, De Lima VC, De Camargo Carvalho AC. de Souza CF, et al. Among authors: de souza brito f. J Interv Cardiol. 2010 Apr;23(2):195-202. doi: 10.1111/j.1540-8183.2010.00536.x. Epub 2010 Mar 12. J Interv Cardiol. 2010. PMID: 20337861 Free article. Review.
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.
Holman RR, Bethel MA, Mentz RJ, Thompson VP, Lokhnygina Y, Buse JB, Chan JC, Choi J, Gustavson SM, Iqbal N, Maggioni AP, Marso SP, Öhman P, Pagidipati NJ, Poulter N, Ramachandran A, Zinman B, Hernandez AF; EXSCEL Study Group. Holman RR, et al. N Engl J Med. 2017 Sep 28;377(13):1228-1239. doi: 10.1056/NEJMoa1612917. Epub 2017 Sep 14. N Engl J Med. 2017. PMID: 28910237 Free PMC article. Clinical Trial.